IN2013MU03610A - - Google Patents
Info
- Publication number
- IN2013MU03610A IN2013MU03610A IN3610MU2013A IN2013MU03610A IN 2013MU03610 A IN2013MU03610 A IN 2013MU03610A IN 3610MU2013 A IN3610MU2013 A IN 3610MU2013A IN 2013MU03610 A IN2013MU03610 A IN 2013MU03610A
- Authority
- IN
- India
- Prior art keywords
- dasatinib monohydrate
- abstract
- commercially
- describes
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IN2014/000782 WO2015107545A1 (en) | 2013-12-18 | 2014-12-17 | Water soluble salts of dasatinib hydrate |
| IN3610MU2013 IN2013MU03610A (es) | 2013-12-18 | 2014-12-17 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN3610MU2013 IN2013MU03610A (es) | 2013-12-18 | 2014-12-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2013MU03610A true IN2013MU03610A (es) | 2015-04-24 |
Family
ID=53039939
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN3610MU2013 IN2013MU03610A (es) | 2013-12-18 | 2014-12-17 |
Country Status (2)
| Country | Link |
|---|---|
| IN (1) | IN2013MU03610A (es) |
| WO (1) | WO2015107545A1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019209908A1 (en) | 2018-04-25 | 2019-10-31 | Johnson Matthey Public Limited Company | Crystalline forms of dasatinib |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR0009721A (pt) | 1999-04-15 | 2002-02-13 | Bristol Myers Squibb Co | Inibidores de tirosina quinase de proteìna cìclica |
| TWI338004B (en) | 2004-02-06 | 2011-03-01 | Bristol Myers Squibb Co | Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors |
| US20050215795A1 (en) | 2004-02-06 | 2005-09-29 | Bang-Chi Chen | Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors |
| GEP20104927B (en) | 2005-05-05 | 2010-03-25 | Bristol Myers Squibb Co | Formulations of a src/abl inhibitor |
| ATE505192T1 (de) | 2005-06-09 | 2011-04-15 | Bristol Myers Squibb Co | Pharmazeutische zusammensetzung zur anwendung in der behandlung von personen mit mutant-kit- protein |
| US20070105867A1 (en) | 2005-09-21 | 2007-05-10 | Bristol-Myers Squibb Company | Oral administration of N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-1,3-thiazole-5-carboxamide and salts thereof |
| US20070093499A1 (en) | 2005-10-20 | 2007-04-26 | Bristol-Myers Squibb Company | Use of dasatinib for the treatment of bone metastasis |
| WO2010139979A2 (en) * | 2009-06-03 | 2010-12-09 | Generics [Uk] Limited | Processes for preparing crystalline forms |
| US9145406B2 (en) * | 2012-04-20 | 2015-09-29 | Shilpa Medicare Limited | Process for preparing dasatinib monohydrate |
-
2014
- 2014-12-17 IN IN3610MU2013 patent/IN2013MU03610A/en unknown
- 2014-12-17 WO PCT/IN2014/000782 patent/WO2015107545A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2015107545A1 (en) | 2015-07-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12016501122A1 (en) | Delayed release compositions of linaclotide | |
| PH12016500169A1 (en) | Polymorph of syk inhibitors | |
| MX363347B (es) | Sal de omecamtiv mecarbilo y proceso para preparar la sal. | |
| IN2013MU00646A (es) | ||
| IN2014MU00455A (es) | ||
| MY160902A (en) | Process for the preparation of the L-arginine salt of perindopril | |
| MX360048B (es) | Formas cristalinas de acido { [1-ciano-5-(4-clorofenoxi)-4-hidroxi -isoquinolin-3-carbonil]-amino}-acetico. | |
| IN2013MU03862A (es) | ||
| WO2014141294A3 (en) | An improved process for the synthesis of melphalan and the hydrochloride salt | |
| IN2014CH00304A (es) | ||
| PL2964607T3 (pl) | Sposób wytwarzania halogeno-n,n-dimetylobenzyloamin | |
| IN2013MU01111A (es) | ||
| IN2013MU01113A (es) | ||
| WO2015087343A3 (en) | An improved process for the preparation of nilotinib and pharmaceutically acceptable salts thereof | |
| MX2015005510A (es) | Forma salina solida de la alfa-6-mpeg6-o-hidroxicodona como agonistas opioides y sus usos. | |
| IN2013MU04056A (es) | ||
| EP2981518A4 (en) | IMPROVED PROCESS FOR THE PREPARATION OF FLUVOXAMINE MALEATE | |
| HUP1400104A2 (en) | Compositions comprising indometacine, its pharmaceutically acceptable salts and cocrystals; and process for the preparation | |
| IN2013MU03610A (es) | ||
| GB2564185A (en) | Process for the preparation of derivatives of benzodioxole | |
| IN2013CH04314A (es) | ||
| IN2013MU03565A (es) | ||
| MX2016011534A (es) | Un proceso mejorado para la preparacion de exametazima. | |
| MX2016002186A (es) | Proceso para preparar dronedarona y sales de la misma. | |
| IN2014CH01391A (es) |